Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 1.35% vs 1.52% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is -120.89% vs 314.72% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 41.71% vs -1.88% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is -146.57% vs 228.87% in Mar 2025
Compare Profit and Loss Results of Samrat Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
289.00
70.00
219.00
312.86%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
289.00
70.00
219.00
312.86%
Expenditure (Ex Depriciation)
Stock Adjustments
-6.00
0.00
-6.00
0%
Raw Materials Consumed
289.00
55.00
234.00
425.45%
Power & Fuel Cost
1.00
0.00
1.00
0%
Employee Cost
2.00
4.00
-2.00
-50.00%
Operating Expenses
2.00
0.00
2.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
291.00
64.00
227.00
354.69%
Operating Profit (PBDIT) excl Other Income
-2.00
5.00
-7.00
-140.00%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
-1.00
5.00
-6.00
-120.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
-2.00
5.00
-7.00
-140.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
-2.00
4.00
-6.00
-150.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-2.00
4.00
-6.00
-150.00%
Provision for Tax
0.00
1.00
-1.00
-100.00%
Profit After Tax
-3.00
3.00
-6.00
-200.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
68.00
14.00
54.00
385.71%
Profit Available for appropriations
65.00
18.00
47.00
261.11%
Appropriations
65.00
18.00
47.00
261.11%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-10.72
5.28
-16.00
-303.03%
Profit And Loss - Net Sales
Net Sales 289.72 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 1.35% vs 1.52% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -2.14 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -120.89% vs 314.72% in Mar 2025
Profit And Loss - Interest
Interest 0.96 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 41.71% vs -1.88% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax -3.31 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -146.57% vs 228.87% in Mar 2025
Footer loading
